7th Edition

Lung Cancer Therapy Annual 7

Edited By Rolf A. Stahel Copyright 2012

    Highly Commended, BMA Medical Book Awards 2013

    Oncology research and practice in lung cancer continues to develop rapidly. This latest edition of an acclaimed reference briefs the oncology community with a review of the recent literature, emphasizing the most significant therapeutic advances. The expert contributions of Lung Cancer Therapy Annual 7 offer an update of the impact that this information will have on the day-to-day management of the lung cancer patient.

    New to the seventh edition are four new chapters on the treatment of non-small cell lung cancer (NSCLC) and a new chapter on thymoma. Additional topics include:

    • Oncogenic driver mutations
    • First line therapy of advanced non-small cell lung cancer without activating EGFR mutation
    • Second line therapy of non-small cell lung cancer
    • Adjunct and neoadjunct therapy of non-small cell lung cancer
    • Advances in surgery of lung cancer; advances in radiotherapy of lung cancer
    • Mesothelioma
    • Thymic tumors

    Epidemiology of lung cancer
    Menghua Tao and Paolo Boffetta
    Prevention, early detection and screening
    Giulia Veronesi
    Staging
    Christophe Dooms
    Histo- and molecular pathology of lung cancer
    A. Soltermann, S. Peters, and V. Tischler
    Oncogenic driver mutations
    Hiromichi Ebi and Tetsuya Mitsudomi
    First-line therapy of advanced non-small cell lung cancer not harboring an activating EGFR mutation
    Cesare Gridelli and Antonio Rossi
    First-line therapy of advanced non-small cell lung cancer with activating EGFR mutations
    Caicun Zhou
    Second-line therapy of non-small cell lung cancer
    David F. Heigener, Sabine Bohnet, and Martin Reck
    Adjuvant and neoadjuvant therapy of non-small cell lung cancer
    Alejandro Navarro Mendivil and Enriqueta Felip
    Advances in surgery of lung cancer
    Paul E. Van Schil, Jeroen M. Hendriks, Marjan Hertoghs, Patrick Lauwers, and Cliff K. Choong
    Recent advances in radiotherapy for lung cancer
    Dirk K. M. De Ruysscher and José S.A. Belderbos
    Treatment of small cell lung cancer
    Aleksandar Aleksic and Sanjay Popat
    Mesothelioma
    Emanuela Felley-Bosco and Isabelle Opitz
    Thymic tumors
    Enrico Ruffini, Pier Luigi Filosso, Paolo Lausi, and Alberto Oliaro

    Biography

    Rolf A. Stahel, M.D. is head of the Center for Lung and Thoracic Oncology and Senior Staff Physician at the Clinic of Oncology, University Hospital of Zürich as well as Titular Professor of Medicine at the University of Zürich, Switzerland. He is certified in Internal Medicine and Medical Oncology by both the American and Swiss Board. His major interest is thoracic oncology, including multidisciplinary treatment approaches, translational research, and targeted therapy.

    "This is an excellent resource for beginners as well as advanced specialists in the field. The references are current to the year 2008 and the individual chapters are brief and complete and will give readers a solid foundation in the treatment of lung cancer to build upon."  - K. P. Ravikrishnan, FRCP (C), FACP FCCP(William Beaumont Hospitals)